Condensed Consolidated Balance Sheets (Unaudited) (USD $)	Mar. 31, 2012	Sep. 30, 2011
ASSETS
Cash and cash equivalents	$ 5,268,394	$ 4,260,594
Receivables	101,458	457,337
Prepaid expenses	1,865,682	2,028,531
Inventory used for R&D and manufacturing	1,368,404	1,571,182
Deferred rent - current portion	677,584	703,274
Total current assets	9,281,522	9,020,918
RESEARCH AND OFFICE EQUIPMENT AND LEASEHOLD IMPROVEMENTS-- Less accumulated depreciation and amortization of $2,504,425 and $3,034,018	834,344	1,032,881
PATENT COSTS- less accumulated amortization of $1,332,835 and $1,287,323	386,733	414,158
DEFERRED RENT - net of current portion	6,210,419	6,486,566
DEPOSITS	1,670,917	1,670,917
TOTAL ASSETS	18,383,935	18,625,440
LIABILITIES AND STOCKHOLDERS' EQUITY
Accounts payable	708,089	738,951
Accrued expenses	191,201	290,220
Due to employees	22,420	22,789
Related party loan	1,104,057	1,104,057
Convertible notes	0	4,999,000
Derivative instruments - current portion	0	69,552
Total current liabilities	2,025,767	7,224,569
Derivative instruments - net of current portion	9,983,230	2,192,521
Deferred revenue	126,500	125,000
Deposits held	5,000	0
Deferred rent	1,767	4,526
Total liabilities	12,142,264	9,546,616
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS' EQUITY
Preferred stock, $.01 par value; authorized, 200,000 shares; no shares issued and outstanding	0	0
Common stock, $.01 par value--authorized 450,000,000 shares; issued and outstanding, 256,597,698 and 214,723,023 shares at March 31, 2012 and September 30, 2011, respectively	2,565,977	2,147,230
Additional paid-in capital	203,263,177	194,443,905
Accumulated deficit	(199,587,483)	(187,512,311)
Total stockholders' equity	6,241,671	9,078,824
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 18,383,935	$ 18,625,440